Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Marksans Pharma Ltd. Board/Management Information 2018

Dec 31, 2018

62142_rns_2018-12-31_243aa06e-eb16-4324-a229-ffd17abf1c34.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [191 x 61] intentionally omitted <==

----- Start of picture text ----- ·t·Marksans Pharma Ltd.----- End of picture text -----

To,

National Stock Exchange of India Limited Exchange Plaza C-l, Block 'G'Bandra Kurla Complex Bandra (EL Mumbai - 400051 Scrip Code: MARKSANS

To,

BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Fort Mumbai - 400 001 Scrip Code: 524404

Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015 please be informed that Dr. Vinay Gopal Nayak (DIN: 02577389) has resigned as Director and Whole-time Director of the Company effective from 1[st] January, 2019.

For MjJc'ksa 5 Pha{'~mited

~ OJM

r ~

Harshavardhan Panigrahi Company Secretary & Manager-legal

Marksans Pharma Ltd.

11th FI.oor,"GRAND.EUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andhen (W), Mumbal - 400 053 • Tel.: +91 224001 2000 • E-mail: [email protected] . www.marksanspharma.com